H eart transplantation remains as the only therapy offering long-term survival of children with end-stage heart disease. With an estimated 12 000 to 14 000 pediatric heart failure hospitalizations annually in the United States 1 and the number of heart transplants in children being <400, 2 many children will die waiting for heart transplantation. This is particularly evident in certain subgroups of patients. Overall, ≈1 in 4 infants will die before transplant, 3 and a similar proportion of patients supported with extracorporeal membrane oxygenation will not survive 30 days after being listed for transplantation. 4 Of note, however, is that up to one third of potential pediatric heart donors are never used for heart transplantation, many secondary to concerns about the quality of the donor heart. 5 Perhaps as a corollary of this, there has been little increase in the total number of pediatric heart transplants performed in the past decade. 2 
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Ventricular dysfunction of the donor heart is one of the reasons why a potential donor heart may not be used [5] [6] [7] [8] although it has been well described that brain death may lead to reversible myocardial dysfunction, [9] [10] [11] [12] and successful transplants have been reported with the use of heart from donors with depressed ventricular function. 5, 8, 11, 13 However, there is a paucity of data on the prevalence or outcome of pediatric heart transplantation from donors with depressed ventricular function. Therefore, we aimed to describe the frequency of pediatric heart transplantation from donors with depressed ventricular function and test the hypothesis that heart transplant recipients from donors with depressed ventricular function would have comparable survival with those who received hearts from donors with normal ventricular function.
Methods
A retrospective analysis was performed on data obtained from the United Network of Organ Sharing Database (UNOS) Standard Transplant Analysis and Research files. UNOS is the regulatory agency responsible for the oversight of all solid organ transplantation in the United States. Data are maintained by UNOS on the characteristics of donors, recipients, and follow-up of transplanted patients.
Additional data on potential pediatric donor hearts that were evaluated but not transplanted were provided by UNOS. This study assessed pediatric heart transplants (age <18 years at the time of transplant) in the United States from October 26, 1999 , to June 30, 2011. The initiation date was chosen as the time when UNOS began to routinely recording donor ejection fraction. The study was submitted to the Institutional Review Board of the Children's Hospital of Philadelphia and was determined to be exempt from review as all protected health information was deidentified.
Organ recipients were placed into 1 of 3 groups based on the accepted donor left ventricular function. The classification of the accepted donor left ventricular function was based on the American Society of Echocardiography criteria and are as follows: normal function was defined as a left ventricular ejection fraction (LVEF) of ≥55%; mildly depressed function, a LVEF of 45% to 54%; and moderately-to-severely depressed function, a LVEF of <45%. 14 Only 1 donor echocardiogram is recorded in the database. In the circumstance when >1 echocardiogram is performed, it is not possible to discern which is reported to UNOS.
Statistical Analysis
Data from the UNOS Standard Transplant Analysis and Research files were imported into SAS, version 9.2 (SAS Inc, Cary, NC) for analysis. Baseline data on organ donors and recipients are reported as medians with 25th to 75th percentile or as percentages, as appropriate. Baseline characteristics were compared among the 3 groups of left ventricular function using a Kruskal-Wallis test for continuous variables because the data were not normally distributed. χ 2 tests of independence were performed for categorical variables, including donor trends over time. After dropping 14 patients without graft survival data, follow-up data were available for recipients of 171 donors accepted with moderatelyto-severely depressed ventricular function, 244 donors accepted with mildly depressed ventricular function, and 2877 donors accepted with normal function. Kaplan-Meier survival curves were constructed and log-rank statistics were used to compare overall graft survival among the different groups of accepted donor left ventricular function.
Linear regressions with age and sex as predictors were used for missing data imputation for continuous variables. For the categorical variable, the age and sex specific for most prevalent category were used to replace the missing value. The percentages of missing values are listed in Table I in the online-only Data Supplement. Large differences in recipient age and donor age among the 3 groups of accepted donor ventricular function were noted. Therefore, propensity score matching was used to balance the clinical characteristics between groups. First, logistic regression was used to predict the likelihood of accepting an organ with moderately-to-severely depressed ventricular function versus normal ventricular function using the recipient characteristic variables and donor characteristic variables listed in Tables 1 and 2 , and then, the propensity score generated from the logistic regression were used to match recipients of donors accepted with moderately-to-severely depressed ventricular function group to recipients of donors accepted with normal ventricular function with a 1:1 matching ratio. Finally, a Cox regression model was used to compare the graft survival between these 2 groups, adjusting for geographic region and year of treatment. The same analytic steps were used to compare the graft survival between recipients of donor hearts accepted with mildly depressed left ventricular function and recipients of donor hearts accepted with normal ventricular function. Statistical significance was defined as a 2-tailed P value of <0.05.
Results
There were 3672 pediatric heart transplants performed during the study period and 3306 (90%) had a donor LVEF reported. The median LVEF was 64% (25th-75th percentile, 59%-70%), with 87% of accepted donors having normal left ventricular function and only 5% having moderately-to-severely depressed left ventricular function. During this time period, 1058 potential pediatric donors with moderately-to-severely depressed ventricular function and 408 potential pediatric donors with mildly depressed ventricular function were not transplanted.
All regions of the United States, based on the 11 UNOS regions, performed transplants from donors with depressed ventricular function; however, some regional differences were noted with regard to the percentage of transplants from donors accepted with depressed ventricular function ( Figure 1 ; Table  II in the online-only Data Supplement). More than 20% of the transplants performed in New York and New England (UNOS regions 1 and 9) were accepted from donors with any degree of ventricular dysfunction as compared with 9% to 11% from Southern, Western, and Central regions (UNOS regions 3-8). A similar regional pattern was observed with transplants accepted from donors with moderately-to-severely depressed ventricular function. Overall, there was no consistent trend with respect to UNOS regions with increased acceptance of donor hearts with depressed ventricular function and wait-list duration ( Table II in 
the online-only Data Supplement).
A trend in the proportion of accepted donors with depressed ventricular function over time was noted. Dividing the time period of the study into 3 equal time periods, there were significant differences noted in the proportion of donors accepted with depressed ventricular function across these time periods. In the early era, 1999-2003, 8% of accepted donors had moderately-to-severely depressed ventricular function as compared with only 3% of accepted donors in the most recent era, 2007-2011 ( Figure 2 ). This corresponded to an increase in the proportion of donors accepted with normal function being 83% in the early era and 90% in the most recent era (P<0.001).
Differences were noted among the recipients of accepted donors with depressed versus normal ventricular function ( Table 1 ). Recipients of accepted donors with depressed ventricular function were more likely to be younger and weigh less than the recipients of accepted donors with normal ventricular function. However, the proportion of accepted donor hearts that went to recipients on inotropic support, extracorporeal membrane oxygenation and mechanical ventilation were similar across normal and depressed ventricular function groups. Accepted donors with depressed ventricular function were also more likely to be younger and weighed less than the accepted donors with preserved ventricular function ( Table 2 ; P<0.001 for both). Inotropic support and cardiopulmonary resuscitation were also more common for accepted donors with depressed ventricular function compared with accepted donors with normal function. Donor weight:recipient weight ratio, donor cause of death, cytomegalovirus status of the donor, and the cold ischemic time were similar among accepted donors with normal and depressed ventricular function.
The overall graft survival was similar among recipients of donors accepted from all ventricular function groups. Recipients of accepted donors with normal function had a graft survival (median, 10.6 years) that was similar to recipients of accepted donors with mildly depressed function (median, 9.7 years; P=0.24) and to recipients of accepted donors with moderately-to-severely depressed function (median, 9.1 years; P=0.13; Figure 3 ). The 30-day, 6-month, 1-year, and 5-year survival were also similar among recipients of accepted donors with normal and depressed ventricular function (Table 3) .
With propensity matching, the baseline characteristics were similar between recipients of accepted donors with moderatelyto-severely depressed function and recipients of accepted donors with normal ventricular function ( Table III in the online-only Data Supplement) and between recipients of accepted donors with mildly depressed ventricular function and recipients of accepted donors with normal function ( Table IV in the onlineonly Data Supplement). In these propensity-matched cohorts, recipients of donors accepted with moderately-to-severely depressed ventricular function (hazard ratio, 1.19; 95% confidence interval, 0.80-1.76; P=0.40) and mildly depressed ventricular function (hazard ratio, 1.08; 95% confidence interval, 0.39-1.54; P=0.67) had similar graft mortality compared with accepted donors with normal ventricular function, adjusting for geographic region and year of treatment (Tables 4 and 5 ).
Discussion
This is the largest pediatric study to date reporting outcomes of pediatric heart transplant recipients of donor hearts accepted with depressed ventricular function. There are several important observations from the study that merit special note. The overall use of hearts with any degree of depressed ventricular function is low, being <15% of all transplants, with only 5% of transplants being from donors with moderately-to-severely depressed ventricular function. However, the outcomes of these accepted donor hearts were similar to hearts from donors accepted with normal ventricular function, even after adjustment for era, UNOS region, and baseline characteristics of the donor and recipient.
Importantly, although the outcome of donor hearts accepted with depressed ventricular function was comparable with those accepted with normal function, the use of organs with depressed ventricular function has decreased over time. Only 10% of transplants in the most recent time period were from donors with any degree of depressed ventricular function compared with 17% of donors in the earliest time period. An explanation for this temporal finding is not obviously apparent. Also, not entirely clear is an explanation of the regional differences noted, with more transplants from donors with depressed ventricular function occurring in the Northeast of the United States. One may hypothesize that regions with longer wait lists may be more likely to accept donors with depressed ventricular function; however, there was significant variability of wait-list times among regions with low and high utilization rates of donors with depressed ventricular function. The regions with the greatest use of donor hearts with depressed ventricular function (regions 1 and 9) had median wait-list time of 51 and 27 days, respectively, whereas regions with lowest use of donor hearts with depressed ventricular function (regions 3-8) had a similar variability in wait-list durations, ranging from 33 to 60 days. Regional variation in care has been well documented in other areas of cardiovascular medicine and medicine in general. [15] [16] [17] There were some differences noted in the recipients of accepted donors with depressed ventricular function compared with recipients of accepted donors with normal function and with the donors themselves. Recipients of accepted donors with depressed ventricular function tended to be younger and weigh less. Although not statistically significant, younger recipients had a higher proportion of congenital heart disease. The accepted donors with depressed ventricular function also tended to be younger and weight less and were more likely to be on inotropic support. Age is likely the key factor for many of these findings because age and weight generally track together, and younger patients are more likely to have congenital heart disease as their underlying reason for transplant. Age may have also been an important factor in the decision to accept an organ with dysfunction because the youngest patients have the greatest wait-list mortality. 3 A center may have been willing to accept a perceived greater risk with a donor heart with depressed ventricular function in a patient perceived to have a high risk of not surviving for a potential future opportunity of a donor heart with better ventricular function. It is interesting, however, that other parameters associated with disease severity in the recipient, including mechanical ventilation, inotropes, and extracorporeal membrane oxygenation, were similar among those that received donor hearts with normal or depressed ventricular function.
It is possible that the mechanism of brain death may influence the reversibility of ventricular dysfunction and outcomes after transplantation. [18] [19] [20] In animal models, a rapid increase in intracranial pressure results in significantly greater increases in catecholamines compared with a gradual increase, and this rapid increase has been associated with irreversible myocardial ischemia. 18 In the current study, >50% of the brain death occurred from traumatic injury with a similar distribution of pathogenesis of brain death in accepted donors with normal and depressed ventricular function. The clinical implications of this are unclear. Several studies have demonstrated worse transplant outcomes after traumatic brain injury, 19-21 although this has not been confirmed in larger studies. 22, 23 It is also conceivable that the outcomes of donor hearts accepted with depressed ventricular function were also influenced by the age of the donors. The median age of donors and recipients of donors with moderately-to-severely depressed ventricular function was 2 years. It is possible that it is in these young donors whom the reversibility of ventricular dysfunction is most likely. Younger organs may be more tolerant of hemodynamic perturbations and injury that occur with brain death and ischemia. Whether the routine use of older donors with depressed ventricular function would yield the same results cannot be ascertained from the current study. Aging has been found to reduce the angiogenic response to ischemic injury in animal models 24 and result in greater ischemia reperfusion injury and apoptosis. 25, 26 A loss of cardioprotection and a decreased response to ischemic precondition have also been noted with aging, 27, 28 although this has not been consistent across all studies. 29 In addition, relative to older adult donors, younger adult donors have been associated with some studies with a decreased incidence of cardiac allograft vasculopathy and improved long-term survival. [30] [31] [32] Whether these observations of worse outcomes of donors of older ages also apply across the spectrum of infancy to adolescence is unclear.
Table 4. Cox Regression for Graft Mortality in Propensity-Matched Cohort of Recipients of Donors With Moderatelyto-Severely Depressed Ventricular Function and Recipients of Donors With Normal Function, Adjusting for Geographic Region and Year of Treatment

Table 5. Cox Regression for Graft Mortality in Propensity-Matched Cohort of Recipients of Donors With Mildly Depressed Ventricular Function and Recipients of Donors With Normal Function, Adjusting for Geographic Region and Year of Treatment
The importance of maximal use of potential donor hearts in children awaiting heart transplant cannot be overstated. There persists a high mortality rate while waiting for transplant, especially among the sickest patients. Some groups have advocated the use of marginal donors in pediatric transplantation, contending that there exist little objective data on the criteria for organ acceptability. 5 Bailey et al 5 reported on the outcomes of 29 heart transplant recipients of hearts that were turned down by other centers on the basis of organ quality. These patients had similar post-transplant survival, although this cohort had longer ischemic times (mean, 6.4 versus 4.8 hours). Yet, it would seem that these pleas have gone largely unheeded, as the proportion of donors accepted with any degree of ventricular dysfunction decreased from 17% to 10% during the study period. More than 1400 potential hearts from pediatric donors with some degree of ventricular dysfunction were not transplanted during this time period. It is conceivable that even a modest increase in the use of donors with ventricular dysfunction could result in a meaningful decrease in wait-list mortality without a significant difference in shortor long-term outcomes. As the absolute number of pediatric donors is unlikely to change substantially, strategies to better define acceptable donors are of critical importance.
Limitations
This study has several limitations. It is a retrospective evaluation and the findings may differ from a prospective randomized study, although it is unlikely that such a study would actually be conducted. There are inherent limitations from studies of large databases, including the variability of practices among centers, the lack of a core echocardiography laboratory that reviewed all of the donor studies, and coding errors when data are added to the database. In addition, the analyses are limited to the data that are available. There may be important data, such as other echocardiographic findings, that could influence outcomes but are not recorded in the database. Occasionally, >1 echocardiogram is performed on a donor, and it is unclear which echocardiogram would be included in the database. Some of the echocardiograms from donors accepted with depressed ventricular function may have improved before procurement but are not identified as such in the database. The study is not immune from a type II error, and it is possible that survival differences may be evident with a larger sample size. However, the study did contain every pediatric heart transplant in the United States with a donor echocardiogram recorded during a 10-year time period, and multivariable analysis with and without propensity scores did not find a survival difference.
In addition, the study only includes donor hearts that were actually transplanted. It is important to note that from a retrospective study, one may describe which hearts have been transplanted, which is different from concluding what hearts can or should be transplanted. Although the relatively small number of accepted donor hearts with moderately-to-severely depressed ventricular function fared similarly to accepted donor hearts with normal ventricular function, there may have been unique reasons for the success of these transplants that may not be applicable to other scenarios with a donor heart with the same degree of ventricular dysfunction. Thus, although the limited number of donor hearts accepted with depressed ventricular function fared well, it does not necessarily follow that all donor hearts with depressed ventricular function will fare well. Further study to this end is needed.
Conclusions
Despite these limitations, several conclusions can be reached. Pediatric heart transplantation from donors with depressed ventricular function is uncommon, representing <15% of all transplants. These transplants are more common in the Northeast of the United States and are becoming less common over time. Recipients of hearts from donors accepted with depressed ventricular function were more likely to be younger and weigh less than the recipients of donors accepted with normal function, and, not surprisingly, donor hearts accepted with depressed ventricular function were more likely to be on inotropic support. However, among donor hearts accepted for transplantation, the post-transplant survival of pediatric recipients of donor hearts with depressed and normal ventricular function was similar. This finding was independent of baseline characteristics of the donor and recipient. Thus, the use of donor hearts with depressed ventricular function may be considered in selected pediatric patients.
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